CTA - caption
All blocks test page
Page cards
Diagnosis and treatment
Learn about how macular disease is diagnosed. The optometrist at your local optician’s practice can test sight, prescribe glasses and check for early signs of eye disease using photography or other imaging. It is important to get your eyes checked at least every two years.
Page cards- dark
Diagnosis and treatment
Learn about how macular disease is diagnosed. The optometrist at your local optician’s practice can test sight, prescribe glasses and check for early signs of eye disease using photography or other imaging. It is important to get your eyes checked at least every two years.
Page cards - light
Diagnosis and treatment
Learn about how macular disease is diagnosed. The optometrist at your local optician’s practice can test sight, prescribe glasses and check for early signs of eye disease using photography or other imaging. It is important to get your eyes checked at least every two years.
Page cards - alt
Diagnosis and treatment
Learn about how macular disease is diagnosed. The optometrist at your local optician’s practice can test sight, prescribe glasses and check for early signs of eye disease using photography or other imaging. It is important to get your eyes checked at least every two years.
Downloads list
Filter by:
Sideview 137 - Autumn 2021 (PDF)
(PDF 4.9MB)
Sideview 137 - Autumn 2021 (Word)
(DOCX 1.2MB)
137 - CD1 Track 01 - Introduction
(MP3 1.9MB)
137 - CD1 Track 02 - Track listings
(MP3 1.5MB)
137 - CD1 Track 03 - Welcome from our Chair
(MP3 5MB)
137 - CD1 Track 04 - From the Conference
(MP3 3.2MB)
137 - CD1 Track 05 - Research News in brief
(MP3 3.8MB)
137 - CD1 Track 06 - New research
(MP3 7MB)
137 - CD1 Track 07 - Research project final report
(MP3 3.1MB)
137 - CD1 Track 08 - News
(MP3 3.4MB)
137 - CD1 Track 09 - Past memories, future hopes
(MP3 3.3MB)
137 - CD1 Track 10 - Macular Week 2021
(MP3 3.5MB)
137 - CD1 Track 11 - Virtual consultations
(MP3 4.8MB)
137 - CD2 Track 01 - Track listings
(MP3 1.5MB)
137 - CD2 Track 02 - Regaining your confidence
(MP3 4.1MB)
137 - CD2 Track 03 - Wear yellow for George
(MP3 2.8MB)
137 - CD2 Track 04 - Befriending
(MP3 3.1MB)
137 - CD2 Track 05 - Our counselling service FAQs
(MP3 3.7MB)
137 - CD2 Track 06 - Thirty four years of beating Macular Disease
(MP3 3.9MB)
137 - CD2 Track 07 - Tips for VIPs
(MP3 2.8MB)
137 - CD2 Track 08 - Winter warmers
(MP3 3MB)
137 - CD2 Track 09 - Punctate inner choroidopathy (PIC)
(MP3 3.4MB)
137 - CD2 Track 10 - Technology tips
(MP3 6MB)
137 - CD2 Track 11 - Legacy Matters, Autumn 2021
(MP3 6.4MB)
137 - CD2 Track 12 - Useful contacts
(MP3 6.2MB)
Image wrap left
Image wrap right
Pull quote
name
Pull quote
name
Title related articles
Generous donations to remember our loved ones
Posted: Monday 29 December 2025
Alongside resolutions and well wishes, the New Year is also often a time to remember those who are no longer with us.
Grandsons cycle 44km for grandma, raising £1,000 to Beat Macular Disease
Posted: Friday 19 December 2025
A grandmother has spoken of her pride after her grandsons, aged just 10 and 12 cycled more than 40km to raise more than £1,000 for macular research on her behalf.
Macular disease Christmas tree rounds off church’s 2025 fundraising
Posted: Friday 19 December 2025
A Christmas tree with a difference has rounded off a church community’s year of fundraising - putting macular disease in the spotlight.
CTA btn
CTA btn
Professor Andrew Lotery answers your questions
Posted: Wednesday 5 March 2025
Professor Andrew Lotery discusses the latest approved treatment for wet age-related macular degeneration (AMD), Lytenava and answers your frequently asked questions on treatments and research.
Find out more
Gene therapy trial improves sight in blind toddlers
Posted: Tuesday 4 March 2025
Four toddlers born with a severe form of childhood blindness have experienced “life-changing improvements” to their sight after participating in an experimental gene therapy trial.
Find out more
Syfovre FAQs and next steps for dry AMD and geographic atrophy treatment
Posted: Thursday 30 January 2025
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) decision to reject the first potential treatment for geographic atrophy (GA), or late-stage age-related macular degeneration (AMD) is undoubtedly a disappointing one for those living with the condition. But, what does the decision mean? We answer your questions.
Find out more
People container
Upper text
upper text
Pizza face
Job
lower text
Lower test
Image cards without links
Pizza 1
Pizza 2